Samyang Holdings Corporation, together its subsidiaries, engages in chemical, food, packaging, pharmaceutical, and other businesses in South Korea, China, Japan, Other Asian countries, Europe, and internationally. The company operates through three segments: Food, Chemicals, and Others. It produces and sells engineering plastics, ion exchange resins, BPA chemicals, personal care materials, eco-friendly materials, semiconductor materials, and other chemical materials. The company also offers sugar, starch sugar, flour, sweeteners, wheat, processed foods, and processed oils/fats, as well as water-soluble dietary fibers; health and wellness products; and food service distribution services under the ServeQ brand. In addition, it provides medical devices, anticancer drugs, and drug delivery systems for gene therapeutics. Further, the company manufactures and sells PET bottle and recycles PET chips, as well as aseptic filings; raw materials for household goods and cosmetics; and various skin care products under the brand name ABOUT ME and dermo-bio cosmetics under the MediAnswer brand name. Additionally, it provides IT services comprising IT consulting on system management and integration, and e-business services, as well as solutions in ERP, CRM, KMS, Portal, HR, MES, BI, and mobile services to the public, finance, and manufacturing sectors. The company also engages in research, trading, and leasing activities. It also exports its products. The company was founded in 1924 and is headquartered in Seoul, South Korea.
| 68400 | |
| 68100 | |
| - | |
| 68500 | |
| 67800 | |
| 63000-87900 | |
| 523 237 M | |
| 7 436 K | |
| 3 372 450 M | |
| 991.564 | |
| 0.0517 | |
| 0.906 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Presentation of "Lafullen®" and "Croquis®" Procedures and Clinical Cases... Confirming Product Excellence and Safety Biodegradable Polymer Filler "Lafullen®" Maintains Natural Volume for 2 Years "C...
Yxintent will exclusively sell Lafullen® after conducting clinical trials and approval in China, with Samyang supplying products worth KRW 100 billion over the next five years Long-lasting biodegrada...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
